Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Walmsley

Showing results (91-100 of 199) with videos related to

Pageof 20
Sort By:
The International Journal on Drug Policy|March 9, 2023
The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national eliminationJim Young, Shouao Wang, Charlotte Lanièce Delaunay, et al.
The New England Journal of Medicine|June 28, 2002
Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infectionSharon Walmsley, Barry Bernstein, Martin King, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 16, 2013
A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapyTae Joon Yi, Sharon Walmsley, Leah Szadkowski, et al.
The International Journal on Drug Policy|December 30, 2018
Variation in hepatitis C virus treatment uptake between Canadian centres in the era of direct-acting antiviralsRoy Nitulescu, Jim Young, Sahar Saeed, et al.
AIDS (London, England)|June 29, 2012
Insulin resistance is associated with progression to hepatic fibrosis in a cohort of HIV/hepatitis C virus-coinfected patientsMark W Hull, Kathleen Rollet, Erica E M Moodie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2017
Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIVJim Young, Carmine Rossi, John Gill, et al.
The International Journal on Drug Policy|February 26, 2022
Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in CanadaCharlotte Lanièce Delaunay, Mathieu Maheu-Giroux, Gayatri Marathe, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 21, 2024
Prevalence and Correlates of Frailty Among Older Adults Living With HIV in the CHANGE HIV CohortAlice Zhabokritsky, Marina Klein, Marianne Harris, et al.
Journal of the International AIDS Society|November 22, 2018
Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in CanadaNadine Kronfli, Roy Nitulescu, Joseph Cox, et al.
Lancet (London, England)|July 19, 2011
Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trialJean-Michel Molina, Pedro Cahn, Beatriz Grinsztejn, et al.
Pageof 20

Showing results (91-100 of 199) with videos related to

Sort By:
Pageof 20
The International Journal on Drug Policy|March 9, 2023
The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national eliminationJim Young, Shouao Wang, Charlotte Lanièce Delaunay, et al.
The New England Journal of Medicine|June 28, 2002
Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infectionSharon Walmsley, Barry Bernstein, Martin King, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 16, 2013
A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapyTae Joon Yi, Sharon Walmsley, Leah Szadkowski, et al.
The International Journal on Drug Policy|December 30, 2018
Variation in hepatitis C virus treatment uptake between Canadian centres in the era of direct-acting antiviralsRoy Nitulescu, Jim Young, Sahar Saeed, et al.
AIDS (London, England)|June 29, 2012
Insulin resistance is associated with progression to hepatic fibrosis in a cohort of HIV/hepatitis C virus-coinfected patientsMark W Hull, Kathleen Rollet, Erica E M Moodie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2017
Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIVJim Young, Carmine Rossi, John Gill, et al.
The International Journal on Drug Policy|February 26, 2022
Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in CanadaCharlotte Lanièce Delaunay, Mathieu Maheu-Giroux, Gayatri Marathe, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 21, 2024
Prevalence and Correlates of Frailty Among Older Adults Living With HIV in the CHANGE HIV CohortAlice Zhabokritsky, Marina Klein, Marianne Harris, et al.
Journal of the International AIDS Society|November 22, 2018
Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in CanadaNadine Kronfli, Roy Nitulescu, Joseph Cox, et al.
Lancet (London, England)|July 19, 2011
Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trialJean-Michel Molina, Pedro Cahn, Beatriz Grinsztejn, et al.
Pageof 20